Marcelo V. Negrão
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers 14
- Colorectal Cancer Treatments and Studies 10
- Lung Cancer Research Studies 6
-
- Lung Cancer Treatments and Mutations 28
-
- Cancer Genomics and Diagnostics 10
-
- Melanoma and MAPK Pathways 5
-
- Cardiovascular and exercise physiology 5
-
- Chemotherapy-induced cardiotoxicity and mitigation 5
- Co-authors
- John V. HeymachJianjun ZhangStephen G. SwisherXiuning LeDon L. GibbonsJacqulyne RobichauxJeff LewisWaree Rinsurongkawong
- Journals
- Journal of Clinical Oncology (18 papers)Cancer Research (6 papers)Clinical Cancer Research (2 papers)
- Partner nations
- United StatesBrazilFrance
In The Last Decade
Marcelo V. Negrão
57 papers receiving 761 citations
Peers
Comparison fields: 5 of 67
- Oncology 491
- Pulmonary and Respiratory Medicine 449
- Cancer Research 128
- Molecular Biology 223
- Immunology 66
Countries citing papers authored by Marcelo V. Negrão
This map shows the geographic impact of Marcelo V. Negrão's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcelo V. Negrão with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcelo V. Negrão more than expected).
Fields of papers citing papers by Marcelo V. Negrão
This network shows the impact of papers produced by Marcelo V. Negrão. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcelo V. Negrão. The network helps show where Marcelo V. Negrão may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Marcelo V. Negrão, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 3 | |
| 4 | 2023 | 16 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 36 | |
| 7 | 2023 | 7 | |
| 8 | 2023 | 4 | |
| 9 | 2022 | 6 | |
| 10 | 2021 | 9 | |
| 11 | 2020 | 57 | |
| 12 | 2019 | 17 | |
| 13 | 2019 | 13 | |
| 14 | 2019 | 69 | |
| 15 | 2018 | 4 | |
| 16 | 2018 | 2 | |
| 17 | 2018 | 44 | |
| 18 | 2017 | 63 | |
| 19 | 2017 | 6 | |
| 20 | 2011 | 11 |
About Marcelo V. Negrão
Marcelo V. Negrão is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 65 papers that have together received 769 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (28 papers), Cancer Immunotherapy and Biomarkers (14 papers), Cancer Genomics and Diagnostics (10 papers), Colorectal Cancer Treatments and Studies (10 papers), Lung Cancer Research Studies (6 papers), Melanoma and MAPK Pathways (5 papers), Cardiovascular and exercise physiology (5 papers) and Chemotherapy-induced cardiotoxicity and mitigation (5 papers). The work is most often cited by research in Oncology (491 citations), Pulmonary and Respiratory Medicine (449 citations) and Cancer Research (128 citations). Marcelo V. Negrão has collaborated with scholars based in United States, Brazil and France. Frequent co-authors include John V. Heymach, Jianjun Zhang, Stephen G. Swisher, Xiuning Le, Don L. Gibbons, Jacqulyne Robichaux, Jeff Lewis, Waree Rinsurongkawong, George R. Blumenschein and Emily Roarty. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.